I. Gyselinck, Robin Vos, L. Liesenborghs, P. Verhamme, W. Janssens
{"title":"最新突破摘要-针对新型冠状病毒的直接抗病毒药物:阿奇霉素(DAWn-AZITHRO),一项随机、多中心、开放标签、适应性、概念验证的临床试验","authors":"I. Gyselinck, Robin Vos, L. Liesenborghs, P. Verhamme, W. Janssens","doi":"10.1183/13993003.congress-2021.oa2666","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":45101,"journal":{"name":"Heroin Addiction and Related Clinical Problems","volume":"57 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2021-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial\",\"authors\":\"I. Gyselinck, Robin Vos, L. Liesenborghs, P. Verhamme, W. Janssens\",\"doi\":\"10.1183/13993003.congress-2021.oa2666\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":45101,\"journal\":{\"name\":\"Heroin Addiction and Related Clinical Problems\",\"volume\":\"57 1\",\"pages\":\"\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2021-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heroin Addiction and Related Clinical Problems\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2021.oa2666\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heroin Addiction and Related Clinical Problems","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2021.oa2666","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial